Analyst stock forecast
Adaptive Biotechnologies Forecast: $25.07 Analyst Target
Direct answer
Adaptive Biotechnologies's average price target is $25.07.
The target implies -12.4% from the recorded current price, and the consensus rating is none.
The low target implies -26.6%, the high target implies -2.1%, and the range spans 24.5% of the current price.
Forecast evidence checked September 21, 2026.
Get free Adaptive Biotechnologies email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $28.61
- Average price target
- $25.07
- High price target
- $28.00
- Low price target
- $21.00
- Low target gap
- -26.6%
- Target upside
- -12.4%
- High target gap
- -2.1%
- Target range width
- 24.5%
- Consensus rating
- none
- Analysts
- 7
- Evidence date
- September 21, 2026
- Valid through
- September 28, 2026
Explore related company data
Read the frequently asked questions.
What is Adaptive Biotechnologies's average price target?
Adaptive Biotechnologies's verified average price target is $25.07. The target range is $21.00 to $28.00.
How far are Adaptive Biotechnologies's low and high targets from the recorded price?
The low target implies -26.6%, while the high target implies -2.1%.
How many analysts are included in Adaptive Biotechnologies's consensus?
The verified consensus includes 7 analysts.
How is Adaptive Biotechnologies's target upside or downside calculated?
The average target of $25.07 is divided by the recorded price of $28.61, then one is subtracted to produce -12.4%. This does not guarantee a future return.
When was Adaptive Biotechnologies's analyst forecast verified?
The data was verified on 2026-09-21. The dataset is valid through 2026-09-28.